Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Autor:
Walter Fiedler, Stefan Schwartz, Jochim Reinert, Klaus Wethmar, Matthias Stelljes, Antonia Beitzen-Heineke
Publikováno v:
Annals of Hematology
Treatment options for relapsed or refractory B-lymphoblastic leukaemia (r/r B-ALL) are limited and the prognosis of these patients remains dismal, but novel immunotherapeutic options such as the anti-CD22 antibody–drug-conjugate Inotuzumab-Ozogamic